Characteristics of patients with PTCL presenting with CNS relapse
Patient . | Diagnosis . | CNS prophylaxis . | Type of CNS relapse . | Marrow involvement . | Survival after CNS involvement, d . |
---|---|---|---|---|---|
1 | PTCL-NOS | No | Leptomeningeal/ cauda equina | Yes | 72 |
2 | PTCL-NOS | No | Leptomeningeal | Yes | 30 |
3 | CD4+/CD56+ hematodermic neoplasm | No | Leptomeningeal/eye | Yes | 47 |
4 | ALCL | Yes | Leptomeningeal | Yes | 65 |
5 | ATLL | No | Leptomeningeal | Yes | 48 |
6 | ATLL | No | Leptomeningeal | No | Not reached |
Patient . | Diagnosis . | CNS prophylaxis . | Type of CNS relapse . | Marrow involvement . | Survival after CNS involvement, d . |
---|---|---|---|---|---|
1 | PTCL-NOS | No | Leptomeningeal/ cauda equina | Yes | 72 |
2 | PTCL-NOS | No | Leptomeningeal | Yes | 30 |
3 | CD4+/CD56+ hematodermic neoplasm | No | Leptomeningeal/eye | Yes | 47 |
4 | ALCL | Yes | Leptomeningeal | Yes | 65 |
5 | ATLL | No | Leptomeningeal | Yes | 48 |
6 | ATLL | No | Leptomeningeal | No | Not reached |
PTCL-NOS indicates peripheral T-cell lymphoma, not otherwise specified; ALCL, anaplastic large cell lymphoma; and ATLL, adult T-cell leukemia/lymphoma.